Mapping gene function at scale: A new CRISPR imaging breakthrough
Broad Institute - 27-Jan-2025PERISCOPE links genes to cell structure, revealing new insights
Join the club for FREE to access the whole archive and other member benefits.
Combating aging and associated diseases. An Alphabet (Google) subsidiary.
Founded in 2013 by Bill Maris.
Calico is a research and development company whose mission is to harness advanced technologies to increase our understanding of the biology that controls lifespan. We will use that knowledge to devise interventions that enable people to lead longer and healthier lives. Executing on this mission will require an unprecedented level of interdisciplinary effort and a long-term focus for which funding is already in place.
Chief scientist, David Botstein, retired late 2022.
Visit website: https://www.calicolabs.com/
Details last updated 04-Feb-2019
PERISCOPE links genes to cell structure, revealing new insights
Fosigotifator and DNL343 miss key goals, sparking calls for deeper analysis and longer studies
Their partnership with Calico focuses on age-related disease treatments
ABBV-CLS-484 enhances anti-tumor immunity and is currently in clinical trials
Selectively inhibits problematic free radicals - potential breakthrough in treatment of chronic diseases & ageing
Global dynamic model of transcriptional regulation in budding yeast